156856-50-7 Usage
Description
(7S,9aS)-tert-Butyl 7-(hydroxymethyl)hexahydro-1H-pyrido[1,2-a]pyrazine-2(6H)-carboxylate is a synthetic derivative of pyrazine with the molecular formula C13H24N2O3. It is classified as a carboxylate ester and features a tert-butyl group, a hydroxymethyl group, and a hexahydro-1H-pyrido[1,2-a]pyrazine-2(6H) ring. (7S,9aS)-tert-Butyl 7-(hydroxymethyl)hexahydro-1H-pyrido[1,2-a]pyrazine-2(6H)-carboxylate's molecular structure indicates potential applications in the pharmaceutical or chemical industries, although further research is necessary to determine its properties and uses.
Uses
Used in Pharmaceutical Industry:
(7S,9aS)-tert-Butyl 7-(hydroxymethyl)hexahydro-1H-pyrido[1,2-a]pyrazine-2(6H)-carboxylate is used as a potential pharmaceutical compound for its unique molecular structure that may offer novel therapeutic applications. The presence of the carboxylate ester group and the hexahydro-1H-pyrido[1,2-a]pyrazine-2(6H) ring suggests that it could be further modified or utilized in the development of new drugs.
Used in Chemical Industry:
In the chemical industry, (7S,9aS)-tert-Butyl 7-(hydroxymethyl)hexahydro-1H-pyrido[1,2-a]pyrazine-2(6H)-carboxylate may be used as a building block or intermediate in the synthesis of more complex molecules. Its unique structure could be exploited to create new materials or chemical products with specific properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 156856-50-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,8,5 and 6 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 156856-50:
(8*1)+(7*5)+(6*6)+(5*8)+(4*5)+(3*6)+(2*5)+(1*0)=167
167 % 10 = 7
So 156856-50-7 is a valid CAS Registry Number.
156856-50-7Relevant articles and documents
Synthesis, SAR and pharmacology of CP-293,019: A potent, selective dopamine D4 receptor antagonist
Sanner, Mark A.,Chappie, Thomas A.,Dunaiskis, Audrey R.,Fliri, Anton F.,Desai, Kishor A.,Zorn, Stevin H.,Jackson, Elisa R.,Johnson, Celeste G.,Morrone, Jean M.,Seymour, Patricia A.,Majchrzak, Mark J.,Faraci, W. Stephen,Collins, Judith L.,Duignan, David B.,Di Prete, Cecilia C.,Lee, Jae S.,Trozzi, Angela
, p. 725 - 730 (1998)
A series of novel, potent and selective pyrido[1,2-a]pyrazine dopamine D4 receptor antagonists are reported including CP-293,019 (D4 K(i) = 3.4 nM, D2 K(i) > 3,310 nM), which also inhibits apomorphine-induced hyperlocomotion in rats after oral dosing.
